Nengjiang Zhao

Shuxie-1 Decoction Alleviated CUMS -Induced Liver Injury via IL-6/JAK2/STAT3 Signaling

Suhuan Liu, Shuyu Yang, Caoxin Huang, 2022, Frontiers in Pharmacology.

Corilagin Alleviates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced C57BL/6 Mice by Ameliorating Oxidative Stress and Restoring Autophagic Flux

Nengjiang Zhao, Rongwen Zhang, Gang Wei, 2020, Frontiers in Pharmacology.

Curcumin suppresses Notch-1 signaling: Improvements in fatty liver and insulin resistance in rats

Nengjiang Zhao, M. Liao, Jingjing Wu, 2017, Molecular medicine reports.

Akt-mTOR signaling is involved in Notch-1-mediated glioma cell survival and proliferation.

Ling Lin, Nengjiang Zhao, Mingfang Zhang, 2010, Oncology reports.

Effects of simvastatin on serum adiponectin: a meta-analysis of randomized controlled trials

Nengjiang Zhao, Zhuo Huang, Weibing Chen, 2017, Lipids in Health and Disease.

Exploring the mechanism of PingTang No.5 capsule on nonalcoholic fatty liver disease through network pharmacology and experimental validation.

Zhi-Liang Ji, Suhuan Liu, Shuyu Yang, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Interaction of Bmal1 and eIF2α/ATF4 pathway was involved in Shuxie compound alleviation of circadian rhythm disturbance-induced hepatic endoplasmic reticulum stress.

Suhuan Liu, Shuyu Yang, Caoxin Huang, 2023, Journal of ethnopharmacology.